Rizzieri, D. A., Long, G. D., Gasparetto, C., Smith, C. S., Vredenburgh, J. J., Morris, A. K., … Chao, N. J. (2000). Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia. BLOOD, 96(11), 385A-385A.

Rizzieri, D. A., G. D. Long, C. Gasparetto, C. S. Smith, J. J. Vredenburgh, A. K. Morris, W. P. Petros, et al. “Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia.” BLOOD 96, no. 11 (November 16, 2000): 385A-385A.

Rizzieri DA, Long GD, Gasparetto C, Smith CS, Vredenburgh JJ, Morris AK, et al. Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia. BLOOD. 2000 Nov 16;96(11):385A-385A.

Rizzieri, D. A., et al. “Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia.” BLOOD, vol. 96, no. 11, AMER SOC HEMATOLOGY, Nov. 2000, pp. 385A-385A.

Rizzieri DA, Long GD, Gasparetto C, Smith CS, Vredenburgh JJ, Morris AK, Petros WP, Loftis J, McDonald CS, Waters-Pick B, Adams DJ, Chao NJ. Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia. BLOOD. AMER SOC HEMATOLOGY; 2000 Nov 16;96(11):385A-385A.